Top Tweets for #trialupdate

about 16 hours ago

At #SOHO2026, Gilles Salles of @MSKCancerCenter shared insights into a Phase I/II trial evaluating DS3790, a novel CD37-directed ADC for non-Hodgkin #lymphoma? 🚨 Find out more here: 🎥 https://t.co/GIdyBoJGA9 #LYMsm #NonHodgkinLymphoma #CaxTx #CTSM #TrialUpdate

1

6

1

564

4 days ago

🚨 Update on the Phase II Restore-PV trial evaluating DISC-3405 in #PolycythemiaVera! @doctorpemm of @UTMDAnderson provided key insights in an interview at #SOHO2026 last week: 👉 https://t.co/OnxAhnhtwX 👈 #MPNsm #TrialUpdate #CTSM @SocietyofHemOnc

0

8

3

0

804

5 days ago

At #WCLC26, Dean Fennell discusses the MIST3 trial, which combines pembrolizumab and bemcentinib, an AXL inhibitor, in relapsed #mesothelioma 🫁📊 Watch: https://t.co/otnnXwapdq #Oncology #LCSM #TrialUpdate #ImmunoOnc @IASLC This video is available on the Lung Cancer Channel on VJOncology, an independent medical education platform, which is supported by Johnson & Johnson and Takeda. Supporters have no influence over the production of content.

0

1

0

413

#Obsession #Muse 🌻🌙

@Uniqo_Williams

11 days ago

The truth about the lone Black juror holding the line in the Lindsay Clancy trial is coming to light—and how they tried to push him out for standing on the evidence tells a whole story. Let's talk about it! ⚖️👇🏾 #LindsayClancy #TrueCrime #LegalNews #TrialUpdate

0

2

1

0

125

15 days ago

The countdown to #IMS2026 is on! ⏳ We'll be bringing you exclusive insights on the latest data, clinical advances & breakthroughs in #MultipleMyeloma. �� 23–26 Sept 2026 📍 Glasgow, Scotland 🎥 Full coverage on https://t.co/Vqyt4af67F #MMsm #Myeloma #TrialUpdate #CTSM @My @Myeloma_Society

VJHemOnc's tweet photo. The countdown to #IMS2026 is on! ⏳

We'll be bringing you exclusive insights on the latest data, clinical advances & breakthroughs in #MultipleMyeloma.

📅 23–26 Sept 2026
📍 Glasgow, Scotland
🎥 Full coverage on https://t.co/Vqyt4af67F

#MMsm #Myeloma #TrialUpdate #CTSM @Myeloma_Society

0

5

3

0

812

17 days ago

At #EHA2026, @RadiaDeepti of @GSTTnhs shared updates on the SUMMIT & APEX trials, assessing bezuclastinib in systemic mastocytosis. Click here to watch the full interview: 🎥 https://t.co/EjcctVeHPB #TrialUpdate #CTSM #RareDisease #Hematology #HemOnc

1

3

1

2

859

18 days ago

In an interview from #ASCO26, Heinz-Josef Lenz shares interim results from the CRDF-004 trial of onvansertib, a selective PLK1 inhibitor, + #chemotherapy + bevacizumab in first-line RAS-mutated #mCRC 📊🧬 Watch: https://t.co/wEZxkO7DXj #Oncology #TrialUpdate #CRCSM @ASCO #ColorectalCancer This video is available on the GI Cancer Channel on VJOncology, an independent medical education platform, which is supported by Gilead Sciences (Silver) and Revolution Medicines (Silver). Supporters have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

0

3

2

0

527

Crime Talk with Scott Reisch

18 days ago

🎥 This #WorldLeukemiaDay watch @zucenka (@VU_LT) discuss data from a study investigating venetoclax combinations in FLT3- and IDH1-mutated acute myeloid #Leukemia: 👉 https://t.co/WqgH3iUidl 👈 #Leusm #TrialUpdate #WLD26 #LeukemiaAwareness

1

3

2

1

762

Thinking in Cases

@ThinkingInCases

19 days ago

Jurors in Lindsay Clancy’s murder trial have been sent home for the day. Earlier, defense attorney Kevin Reddington requested a juror’s removal, alleging they refused to follow the judge’s instruction on reasonable doubt. #LindsayClancy #TrialUpdate

4

8

1

0

907

Thinking in Cases

@ThinkingInCases

19 days ago

Lindsay Clancy trial update: The judge reminded jurors that they must follow his instructions and reread the instruction on reasonable doubt, according to courtroom reporter Nate Eaton’s 3:25 p.m. update. #LindsayClancy #TrialUpdate

1

6

0

1

2K

@CrimeTalkNet

20 days ago

Jurors in the Lindsay Clancy trial remain deadlocked after 27 hours of deliberation. A woman was arrested for filming jurors, adding a twist to the ongoing case. The jury is reevaluating evidence and considering a possible mistrial. #LegalDrama #TrialUpdate #CrimeTalk

0

10

1

0

586

Watcher Reports @WatcherReports

26 days ago

Watch our recent interview with @ben_schlechter at #ESMOGI26 to hear about the study design of the BATTMAN trial, evaluating botensilimab + balstilimab in hepatic and non-hepatic MSS #mCRC 💉 🔗https://t.co/CHnXJ8bqYW #TrialUpdate #Oncology #ColorectalCancer #CRCSM #ImmunoOnc @myESMO @DanaFarberNews This video is available on the GI Cancer Channel on VJOncology, an independent medical education platform, which is supported by Gilead Sciences (Silver) and Revolution Medicines (Silver). Supporters have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

0

2

1

0

570

MSN @MSN

26 days ago

🏛️ Jurors are now preparing to deliberate in one of the most closely watched criminal trials in Massachusetts. 🔗 https://t.co/vQke3nDDH6 #LindsayClancy #TrialUpdate #CourtNews

MSN's tweet photo. 🏛️ Jurors are now preparing to deliberate in one of the most closely watched criminal trials in Massachusetts.

🔗 https://t.co/vQke3nDDH6

#LindsayClancy #TrialUpdate #CourtNews https://t.co/tUAjqGPJOt

1

0

801

29 days ago

Psychotic break or calculated plan? Medical records revealed in court contradict key defense claims. #LindsayClancy #TrialUpdate #LegalBreakdown

1

5

0

1

564

about 1 month ago

At #ASCO26, @benweinbergmd presents results from the NAPOLI-2 trial of fluorouracil, leucovorin, and nanolioposomal irinotecan for second-line advanced #BTC 📊💉 Watch: https://t.co/sqzdLuiVJe #Oncology #BiliaryTractCancer #TrialUpdate @ASCO This video is available on the GI Cancer Channel on VJOncology, an independent medical education platform, which is supported by Gilead Sciences (Silver) and Revolution Medicines (Silver). Supporters have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

0

2

1

0

509

about 1 month ago

At #ESMOGI26, @LorenzaRimassa presents findings from the SIERRA study of STRIDE as a first-line therapy for #uHCC 📊🩺 Watch: https://t.co/CblgNkwufy #Oncology #LiverCancer #HPBCsm #TrialUpdate @myESMO #ImmunoOnc This video is available on the GI Cancer Channel on VJOncology, an independent medical education platform, which is supported by Gilead Sciences (Silver) and Revolution Medicines (Silver). Supporters have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

0

3

2

0

585

about 1 month ago

🎥 @Dagostino_MD of @unito discusses the impact of sustained MRD negativity on long-term outcomes in transplant-eligible patients with newly diagnosed #MultipleMyeloma enrolled in the Phase II FORTE trial: 👉 https://t.co/8sG27ZkMkS 👈 #MMSM #Myeloma #CTSM #TrialUpdate #HemOnc

0

3

2

1

746